ベータ
治験レーダーAI

AstraZeneca が主要治験依頼者または共同研究者として関与する治験について話し合い、探索しましょう。

場所 日本 に一致する糖尿病の治験(臨床試験)を表示しています。

健康状態や治療法を理解し、近くの治験を探すお手伝いができます。
私たちの検索ツールは英語のみをサポートしています。他の言語で検索と議論するには、上の治験レーダーを使用するか、以下の疾患と場所のフィルターを選択してください。
30 結果
  
疾患名
糖尿病
×
 
場所
日本
×
 
種類
医薬品
×
 
試験タイトル
状況
2型糖尿病の成人におけるAZD5004の1日1回経口投与の有効性、安全性、および耐容性に関する研究（26週間） (SOLSTICE) NCT06579105
完了
Japan Dose Regimen Study of AZD1656 in Japanese Type 2 Diabetes Mellitus Patients NCT01152385
完了結果公開
Trial to Evaluate the Efficacy and Safety of Dapagliflozin in Japanese Type 2 Diabetes Mellitus Patients NCT00972244
完了結果公開
A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus (THEMIS) NCT01991795
完了結果公開
Drug-drug Interaction Study of Dapagliflozin With Voglibose in Japanese Type 2 Diabetes Mellitus Patients NCT01055652
完了
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes (DEPICT 2) NCT02460978
完了結果公開
Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus NCT00935532
完了結果公開
Phase IV Study With a 36-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin Therapy When Added to the Therapy of Japanese Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin. NCT02157298
完了結果公開
The PK and PD of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM NCT02582840
完了結果公開
The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM NCT02582814
完了結果公開
A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects NCT00917267
完了結果公開
A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetes NCT00382239
完了
Phase I Multiple-Ascending Dose (Japan) (MAD) NCT00538174
完了
Safety and Tolerability Study of Cotadutide in Japanese Obese Subjects With Type 2 Diabetes Melitus NCT04208620
完了
A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 Diabetes NCT00612794
完了
To Study Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1656 in Japanese Type 2 Diabetes Mellitus (T2DM) Patients (JMAD) NCT00916604
完了
Safety and Tolerability Study of MEDI0382 in Japanese Preobese or Obese Subjects With Type 2 Diabetes NCT03645421
完了結果公開
Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s) NCT00577824
完了結果公開
Dose Response Study in Japanese Patients NCT00261417
中止
Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes Mellitus NCT01294436
完了結果公開
A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD NCT02547935
完了結果公開
A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus NCT04515849
完了結果公開
A Study to Investigate Multiple Ascending Doses of AZD5004 in Healthy Japanese Participants and Participants With Type 2 Diabetes Mellitus NCT06703658
完了
Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes Mellitus NCT01294423
完了結果公開
Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events (DECLARE-TIMI58) NCT01730534
完了結果公開
2型糖尿病の有無を問わない肥満および過体重の成人を対象とした、AZD9550単独投与およびAZD6234併用投与の安全性を検討する試験 (CONTEMPO) NCT06151964
実施中／登録終了
A Phase 2b Diabetic Kidney Disease Study NCT04170543
完了結果公開
健康成人を対象としたAZD5004のミチグリニドおよびピオグリタゾンへの影響を検討する試験 NCT07444424
募集中
Efficacy, Safety and Tolerability of AZD9977 and Dapagliflozin in Participants With Heart Failure and Chronic Kidney Disease (MIRACLE) NCT04595370
完了結果公開
A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease NCT04492722
中止結果公開